PRIMODOG, ενέσιμο εναιώρημα για σκύλους
PRIMODOG, ενέσιμο εναιώρημα για σκύλους
Authorised
- Canine parvovirus, strain Cornell 780916, Live
Product identification
Medicine name:
PRIMODOG, ενέσιμο εναιώρημα για σκύλους
Active substance:
- Canine parvovirus, strain Cornell 780916, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain Cornell 780916, Live100000.00/cell culture infective dose 501.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 26177/02-04-2021/K-0088401
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 27/03/2023
How useful was this page?:
